R. Dal Bello

Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia

K. Stegmaier, E. Clappier, H. Dombret, 2022, Leukemia.

The Folate Cycle Enzyme MTHFR is a Critical Regulator of Cell Response to MYC-Targeting Therapies.

K. Stegmaier, J. Qi, H. Dombret, 2019, Cancer discovery.

Granulomonocytic progenitors are key target cells of azacytidine in higher risk myelodysplastic syndromes and acute myeloid leukemia

J. Soulier, E. Clappier, H. Dombret, 2018, Leukemia.

A multiparametric niche-like drug screening platform in acute myeloid leukemia

E. Clappier, H. Dombret, C. Preudhomme, 2022, Blood Cancer Journal.

Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively

E. Clappier, H. Dombret, A. Plesa, 2022, HemaSphere.